Filter
474
Text search:
Cognitive
profile
Featured
Recommendations
38
New Publications
105
Language
Document type
No document type
326
Studies & Reports
55
Guidelines
53
Manuals
20
Strategic & Response Plan
8
Training Material
6
Fact sheets
5
Resource Platforms
1
Countries / Regions
India
21
Global
17
South Africa
13
Western and Central Europe
12
Kenya
7
Nigeria
6
Uganda
6
Philippines
6
Nepal
6
Syria
6
Eastern Europe
6
Sierra Leone
5
Bangladesh
5
Ukraine
5
Latin America and the Carribbean
5
Africa
5
Ethiopia
4
Ghana
4
South Sudan
4
Malawi
4
Namibia
4
Myanmar / Burma
4
Liberia
3
Zambia
3
Tanzania
3
Rwanda
3
Indonesia
3
Lesotho
3
Congo, Democratic Republic of
2
USA
2
Cameroon
2
Zimbabwe
2
Germany
2
Cambodia
2
Mozambique
2
Botswana
2
South–East Asia Region
2
Russia
2
Haiti
1
Somalia
1
Iraq
1
Egypt
1
Ireland
1
Sudan
1
Eswatini/ Swaziland
1
Brazil
1
Colombia
1
Madagascar
1
Paraguay
1
Venezuela
1
Canada
1
Tajikistan
1
Georgia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
128
Public Health
37
Women & Child Health
27
Clinical Guidelines
25
Key Resources
19
Capacity Building
11
Toolboxes
Mental Health
155
Disability
40
HIV
26
Planetary Health
17
COVID-19
16
NCDs
16
Global Health Education
11
Caregiver
8
Conflict
7
Refugee
6
Natural Hazards
4
NTDs
4
Malaria
4
Zika
3
TB
3
Ebola & Marburg
2
Rapid Response
2
Social Ethics
2
Pharmacy
2
AMR
1
Health Financing Toolbox
1
2.0 Rapid Response
1
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
Biodiversity and Health in the Face of Climate Change pp 47–66
This chapter reviews the emerging importance of pollen allergies in relation to ongoing climate change. Allergic diseases have been increasing in prevalence over the last decades, partly as the result of the impact of climate change.
...
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South
American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention
and rehabilitation (CVDPR). In the context of the imple
...
Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,
...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance in this guideline is not based on toxicological assessments of the safety of individual no
...
Externalising disorders
Chapter D.2
H2 TIC disorders
recommended
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
Participant Manual September 2009
There is growing international consensus that food systems transformation is important to address the challenges of malnutrition in all its forms, the burden of noncommunicable diseases (NCDs), environmental sustainability, increasing inequality and ensuring the welfare of workers and animals. In li
...
An action research conducted in Bang Shau village Northern Shan State, Myanmar
Developmental disorders
Chapter C.2
2014 Edition
Q3: What approaches are available to enable non-specialized health care providers to identify children with intellectual disabilities, including intellectual disabilities due to specific causes?
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Accessed: 26.02.2020
SCOPING QUESTION: In adults with established status epilepticus (i.e., seizures persisting after the first-line treatment with benzodiazepines [or benzodiazepines-resistant status epilepticus]), which anti-epileptic medications are associated with cessation of seizures and reduced adverse effects)?
...